icon_loop icon_cart icon_arrow-down icon_pick-winners icon_make-better-decisions icon_gofaster-gosmarter icon_equio icon_custom-research icon_conquer-the-wild icon_be-anonymous-and-secure icon_analyst-reports icon_access-realtime-data icon_youtube icon_twitter icon_linkedin icon_facebook

Acquisition-Side Due Diligence in The Legal Cannabis Industry: Approach and Expectations for Both Sides

By Greg Chin, Kevin Michaelan and Jeffrey Michelson, Partner Continuing with the topic of industry trends from our last post, we explore the art of acquisition-side due diligence from full-scope financial and tax to limited-scope tax-only engagements.  We’ll look at what to expect and how to approach it.  Although commonly geared toward the investor/acquirer, i.e., […]
Read more

Medical Cannabis, Texas-Style: Conditions and Requirements for Use

By Ashley Simpson, Hoban Law Group In 2015, the Texas legislature’s passage of the Texas Compassionate Use Act (Senate Bill 339) legalized medical cannabis in the Lone Star State, but only to the extent of "low-THC cannabis oil" for use by patients diagnosed with intractable epilepsy. Widening further access to any patients respectively diagnosed with […]
Read more

Planning for the Coming Consolidation in the Cannabis Industry

By Michael Harlow, CPA, Partner In today’s Cannabis marketplace, we continue to hear one overarching theme.  The industry buzz on everyone’s lips is about “the future consolidation of the industry. This is driven by several factors: strong customer and revenue growth for retailers, price compression for wholesalers, an expected change in the legal landscape, new […]
Read more

The Impact of Regulations on Price

By Yona Torres, New Frontier Data Contributing Editor In the 16 months since California legalized marijuana, cannabis prices in some California market sectors have plummeted 75%, according to the Washington Post. This steep decline, paralleled in Colorado, Oregon and Washington, is a product of the number of newly-licensed cultivators and the regulations that guide them. […]
Read more

America’s Wounded Veterans Need and Want Medical Cannabis; It is Time the Federal Government Provides It

By Joseph Romm, Ph.D. What We Have Learned: Given the potential for medicinal cannabis in the treatment of chronic pain, opioids addiction, and other conditions plaguing veterans, it is time for the federal government to afford them access to it. July 30, 2017 -- Scientific evidence is growing that medical cannabis may provide some promising […]
Read more

Five Components to Look for Out of California and Cannabis Markets at Large

By J.J. McCoy, Senior Managing Editor for New Frontier Data What We Have Learned:  Figuring where California’s example and output will lead the world can make the proverbial $64,000 question seem like a rounding error. August 27, 2017 -- New Frontier Data constantly examines various dimensions of the industry to identify, quantify and holistically discern its […]
Read more

On-Demand Services Become Vital Within the Maturing Retail Marketplace

By J.J. McCoy, Senior Managing Editor for New Frontier Data What We Have Learned: As the cannabis industry grows ever larger and more competitive, the ability to identify the “who”, “what”, and “when” in purchasing habits will be imperative to retailers, and essential for one’s overall enterprise. (Sept.3, 2017) -- With the advent of California’s adult […]
Read more

Business Challenges Intensify Amid Falling Prices in California

By J.J. McCoy, Senior Managing Editor for New Frontier Data What We Have Learned: Falling prices in the expanded California markets will drive operators to focus on per­formance efficiency and cost savings even while trying to establish branding and consumer engagement. (Sept. 10, 2017) -- As the burgeoning cannabis market has started to mature in markets […]
Read more

Cannabis Investors Would Do Well to Keep These Three Tenets in Mind

Mitch Baruchowitz, Managing Partner at Merida Capital Partners What We Have Learned: Focus on adoption and make sure that investments have crossed the “fragmentation gap”, find management teams who have direct experience with the types of challenges they will face in their cannabis enterprise, and look for companies that serve large addressable markets that naturally […]
Read more

An Rx for Returns: Medical Markets Remain Sound for Investment in 2018

By New Frontier Data staff analysts What We Have Learned: With an annual GDP that would rank by itself as the world’s sixth-largest national economy, California will best the top three U.S. medical cannabis markets by revenue in 2018. Oct. 1, 2017: Next month will mark a year since millions of Americans successfully voted to […]
Read more